180 related articles for article (PubMed ID: 36794815)
1. Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program.
Brezina S; Borkovec M; Baierl A; Bastian F; Futschik A; Gasche N; Gruenberger T; Hallas M; Jannsen C; Leeb G; Lutz R; Sladek B; Gsur A
Gut Microbes; 2023; 15(1):2176119. PubMed ID: 36794815
[TBL] [Abstract][Full Text] [Related]
2. DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
Baxter NT; Koumpouras CC; Rogers MA; Ruffin MT; Schloss PD
Microbiome; 2016 Nov; 4(1):59. PubMed ID: 27842559
[TBL] [Abstract][Full Text] [Related]
3. Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening.
Krigul KL; Aasmets O; Lüll K; Org T; Org E
Sci Rep; 2021 Oct; 11(1):19603. PubMed ID: 34599256
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Fecal Sample Collection Methods for Microbial Analysis Embedded within Colorectal Cancer Screening Programs.
Zouiouich S; Mariadassou M; Rué O; Vogtmann E; Huybrechts I; Severi G; Boutron-Ruault MC; Senore C; Naccarati A; Mengozzi G; Kozlakidis Z; Jenab M; Sinha R; Gunter MJ; Leclerc M
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):305-314. PubMed ID: 34782392
[TBL] [Abstract][Full Text] [Related]
5. Reusing a prepaid health plan's fecal immunochemical tests for microbiome associations with colorectal adenoma.
Goedert JJ; Wu Z; Yonehara CH; Frankland TB; Sinha R; Jones GS; Wan Y; Ravel J; Zhao N; Honda SA
Sci Rep; 2022 Aug; 12(1):14801. PubMed ID: 36045142
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study.
Goedert JJ; Gong Y; Hua X; Zhong H; He Y; Peng P; Yu G; Wang W; Ravel J; Shi J; Zheng Y
EBioMedicine; 2015 Jun; 2(6):597-603. PubMed ID: 26288821
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Methods To Collect Fecal Samples for Microbiome Studies Using Whole-Genome Shotgun Metagenomic Sequencing.
Byrd DA; Sinha R; Hoffman KL; Chen J; Hua X; Shi J; Chia N; Petrosino J; Vogtmann E
mSphere; 2020 Feb; 5(1):. PubMed ID: 32250964
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility, stability, and accuracy of microbial profiles by fecal sample collection method in three distinct populations.
Byrd DA; Chen J; Vogtmann E; Hullings A; Song SJ; Amir A; Kibriya MG; Ahsan H; Chen Y; Nelson H; Knight R; Shi J; Chia N; Sinha R
PLoS One; 2019; 14(11):e0224757. PubMed ID: 31738775
[TBL] [Abstract][Full Text] [Related]
9. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants.
Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB
BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
11. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
12. Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy.
Young C; Wood HM; Fuentes Balaguer A; Bottomley D; Gallop N; Wilkinson L; Benton SC; Brealey M; John C; Burtonwood C; Thompson KN; Yan Y; Barrett JH; Morris EJA; Huttenhower C; Quirke P
Clin Cancer Res; 2021 Apr; 27(8):2246-2254. PubMed ID: 33658300
[TBL] [Abstract][Full Text] [Related]
13. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population.
Iadsee N; Chuaypen N; Techawiwattanaboon T; Jinato T; Patcharatrakul T; Malakorn S; Petchlorlian A; Praditpornsilpa K; Patarakul K
Sci Rep; 2023 Apr; 13(1):6702. PubMed ID: 37095272
[TBL] [Abstract][Full Text] [Related]
15. Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling.
Short MI; Hudson R; Besasie BD; Reveles KR; Shah DP; Nicholson S; Johnson-Pais TL; Weldon K; Lai Z; Leach RJ; Fongang B; Liss MA
BMC Microbiol; 2021 Jan; 21(1):26. PubMed ID: 33446094
[TBL] [Abstract][Full Text] [Related]
16. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
Chen H; Werner S; Brenner H
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
[TBL] [Abstract][Full Text] [Related]
17. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions.
Baxter NT; Ruffin MT; Rogers MA; Schloss PD
Genome Med; 2016 Apr; 8(1):37. PubMed ID: 27056827
[TBL] [Abstract][Full Text] [Related]
18. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
19. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
20. Profiling small RNAs in fecal immunochemical tests: is it possible?
Birkeland E; Ferrero G; Pardini B; Umu SU; Tarallo S; Bulfamante S; Hoff G; Senore C; Rounge TB; Naccarati A
Mol Cancer; 2023 Oct; 22(1):161. PubMed ID: 37789383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
